Ventricular Tachycardia Ablation

  • Neil T. SrinivasanEmail author
  • Alex Cambridge


Ventricular tachycardia (VT) ablation can in many cases be one of the most challenging areas of invasive electrophysiology. Reducing symptoms associated with VT and reducing the morbidity associated with ICD shocks remain the most common indications for VT ablation. There are three broad categories of VT: VT secondary to ischaemic heart disease, non-ischaemic heart disease, and normal heart VT. The approaches to ablation in each setting are slightly different and are outlined here.


Monomorphic ventricular tachycardia Polymorphic ventricular tachycardia Ventricular fibrillation Substrate ablation Late potentials 


  1. 1.
    Nanthakumar K, Epstein AE, Kay GN, Plumb VJ, Lee DS. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol. 2004;44:2166–72.CrossRefGoogle Scholar
  2. 2.
    Connolly SJ, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. JAMA. 2006;295:165–71.CrossRefGoogle Scholar
  3. 3.
    Al-Khatib SM, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. Heart Rhythm. 2018;15:e73–189.CrossRefGoogle Scholar
  4. 4.
    Sapp JL, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375:111–21.CrossRefGoogle Scholar
  5. 5.
    Anter E, Tschabrunn CM, Buxton AE, Josephson ME. High-resolution mapping of postinfarction reentrant ventricular tachycardia: electrophysiological characterization of the circuit. Circulation. 2016;134:314–27.CrossRefGoogle Scholar
  6. 6.
    Stevenson WG, Soejima K. Catheter ablation for ventricular tachycardia. Circulation. 2007;115:2750–60.CrossRefGoogle Scholar
  7. 7.
    Stevenson WG, et al. Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping. J Am Coll Cardiol. 1997;29:1180–9.CrossRefGoogle Scholar
  8. 8.
    Stevenson WG, et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation. 1993;88:1647–70.CrossRefGoogle Scholar
  9. 9.
    Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000;101:1288–96.CrossRefGoogle Scholar
  10. 10.
    Arenal A, et al. Ablation of electrograms with an isolated, delayed component as treatment of unmappable monomorphic ventricular tachycardias in patients with structural heart disease. J Am Coll Cardiol. 2003;41:81–92.CrossRefGoogle Scholar
  11. 11.
    Vergara P, et al. Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation. J Cardiovasc Electrophysiol. 2012;23:621–7.CrossRefGoogle Scholar
  12. 12.
    Santangeli P, Marchlinski FE. Substrate mapping for unstable ventricular tachycardia. Heart Rhythm. 2016;13:569–83.CrossRefGoogle Scholar
  13. 13.
    Jaïs P, et al. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation. 2012;125:2184–96.CrossRefGoogle Scholar
  14. 14.
    Di Biase L, et al. Ablation of clinical stable ventricular tachycardia versus substrate based ablation on long term freedom from any VT: results from a randomized multicenter study vista. Heart Rhythm. 2014.Google Scholar
  15. 15.
    Biase LD, et al. Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2012;60:132–41.CrossRefGoogle Scholar
  16. 16.
    Arenal A, et al. Tachycardia-related channel in the scar tissue in patients with sustained monomorphic ventricular tachycardias: influence of the voltage scar definition. Circulation. 2004;110:2568–74.CrossRefGoogle Scholar
  17. 17.
    de Chillou C, et al. Localizing the critical isthmus of postinfarct ventricular tachycardia: the value of pace-mapping during sinus rhythm. Heart Rhythm. 2014;11:175–81.CrossRefGoogle Scholar
  18. 18.
    Szumowski L, et al. Mapping and ablation of polymorphic ventricular tachycardia after myocardial infarction. J Am Coll Cardiol. 2004;44:1700–6.CrossRefGoogle Scholar
  19. 19.
    Sosa E, Scanavacca M. Percutaneous pericardial access for mapping and ablation of epicardial ventricular tachycardias. Circulation. 2007.

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Bart’s Heart Centre, St Bartholomew’s HospitalLondonUK

Personalised recommendations